Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcus Biosciences, Inc.(RCUS) | 31,424,760 | 31,424,760 | 0 | $678.77M | $968.83M | 58.76% | +$290.05M |
| Lakefront Biotherapeutics NV(LKFT) | 16,707,477 | 16,707,477 | 0 | $501.22M | $500.16M | 30.34% | -$1.07M |
| Assembly Biosciences Inc. | 4,505,391 | 4,977,089 | +471,698 | $125.02M | $136.77M | 8.30% | +$11.75M |
| Kyverna Therapeutics Inc. | 4,126,119 | 4,126,119 | 0 | $35.61M | $36.76M | 2.23% | +$1.16M |
| Xilio Therapeutics Inc. | 650,389 | 650,389 | 0 | $5.47M | $6.23M | 0.38% | +$761.0K |
| Arcellx Inc COMMON STOCK | 6,720,803 | 0 | -6,720,803 | $771.68M | $0 | — | -$771.68M |